Patents by Inventor Michael Whitt

Michael Whitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220135920
    Abstract: An intravaginal culture device includes an outer housing configured for vaginal insertion. The outer housing includes an upper portion that removably couples with a lower portion. A first inner vessel is located at the upper portion and is configured to house a first plurality of embryos. A second inner vessel is located at the lower portion and is configured to house a second plurality of embryos.
    Type: Application
    Filed: October 22, 2021
    Publication date: May 5, 2022
    Applicant: REPROHEALTH TECHNOLOGIES, INC.
    Inventors: James Donahue, Michael Whitt, Katherine Russell, Christina Nicole Harrison, Sarah Sanders
  • Publication number: 20060106287
    Abstract: Optical windows for intracorporeal devices, intracorporeal devices comprising a window and a method for forming a window for an intracorporeal device are provided. The method comprises placing within a mold an assembly comprising a mandrel located within a pair of parts separated by a collar of window material, heating the window preform effective to cause the window material to soften, and applying force to urge together the pair of parts to deform the window material so as to form a window. The intracorporeal devices, such as imaging devices, include guidewires, catheters, endoscopes. In addition, the method is suitable for joining plastic parts to other parts, such as metal and ceramic parts.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 18, 2006
    Inventors: William Webler, Michael Whitt, Marc Jalisi, Andrej Chudy, Kevin Phillips, Marc Speck
  • Publication number: 20050260601
    Abstract: The present invention relates to recombinant Rhabdoviridae, isolated nucleic acids, vectors, cells and compositions comprising same. The recombinant Rhabdoviridae, isolated nucleic acids, vectors, cells and compositions express Rhabdoviral proteins including a mutated matrix protein (M) and/or a mutated glycoprotein (G), in addition to expression of at least one foreign nucleic acid. The present invention also relates to methods of use thereof, including their use in vivo, in anti-cancer applications, such as in the treatment of gliomas. The recombinant Rhabdoviridae of the present invention are also useful in gene therapy and vaccine applications.
    Type: Application
    Filed: September 8, 2003
    Publication date: November 24, 2005
    Inventors: Michael Whitt, Clinton Robison, Himangi Jayakar, Mark Miller